HOLLAND & KNIGHT LLP

Lobbying for SOUND PHARMACEUTICALS, INC. · Bio-pharmaceutical platform developing novel treatments to prevent and treat hearing loss

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2026 · Washington · House · Senate · $10,000.00 income · posted Apr 20, 2026

Lobbying activity 4

Budget/Appropriations

Issues related to hearing loss and treatment.

Medical/Disease Research/Clinical Labs

Issues related to hearing loss and treatment.

Defense

Issues related to hearing loss and treatment.

Veterans

Issues related to hearing loss and treatment.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.